Details for 2018876779

Up to date per 01.04.2026

Actions

Title / Product Name

VERWENDUNG VON RILUZOLPRODRUGS ZUR BEHANDLUNG VON ATAXIEN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2018876779

EP Publication Number

3706739

E-Number

1732384

Language

PCT Number

US18060232

Publication Date

16.09.2020 A

16.10.2024 B1

Registration Date

16.10.2024

AT Publication Date

15.11.2024

Application Date

11.11.2018

Registration Number

Priorities

12.11.2017

201762584856 P

13.08.2018

201862717948 P

IPC

A61K 31/428 20060101AFI20210628BHEP

Maximum Duration of Protection

11.11.2038

Owner

Biohaven Therapeutics Ltd.215 Church Street New Haven, CT 06510US

Representative

Patentanwalt Mikšovsky KGBisamberger Straße 192100 KorneuburgAT

Inventor

CORIC, Vladimir215 Church Street New Haven Connecticut 06510US

BERMAN, Robert215 Church Street New Haven Connecticut 06510US

BEINER, Melissa215 Church Street New Haven Connecticut 06510US

L'ITALIEN, Gilbert215 Church Street New Haven Connecticut 06510US

Information about Fees